Graft Maker’s Statements Were Forward-Looking, Not Misleading, Panel Rules
ATLANTA — A federal district court did not err in dismissing a shareholder’s federal securities law claims against a medical technology company and others, alleging that the defendants misrepresented the markets...To view the full article, register now.
Already a subscriber? Click here to view full article